The Maryland Technology Development Corp. is giving a total of $800,000 in investments to four local biotech companies.
Each of the firms will receive a $200,000 grant through TEDCO’s Life Science Investment Fund. The fund was created to help give startup companies in life sciences fields a chance to have their technology validated by the U.S. Food and Drug Administration, and to help further develop the product.
The companies receiving investments are:
AsclepiX Therapeutics, a spinout of Johns Hopkins University that focuses on biotechnology and ophthalmology research.
Sonavex, also a Johns Hopkins spinoff, which produces machinery that can detect blood clots during surgery.
Vasoptic Medical Inc., a South Baltimore company that is creating eye-imaging technology to help those who suffer vision loss due to diabetes.
Gel-e, a College Park-based biotech company that tracks blood flow through patients.
For full story click here.